DD vs NRXS · P/E 127, rev $3.50B vs rev $3.6M
Dupont De Nemours Inc (DD) versus Neuraxis, Inc. (NRXS) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
Latest reported DD revenue for 2026-06-30 was $3.50B. Net income was $304.0M. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. NRXS currently screens at market cap $83.1M.
Not investment advice. Open the DD and NRXS stock pages for the full models.
Not investment advice.